Disease Info Card

Gangliosidosis, Generalized Gm1, Type 1 (disorder)

Information about Gangliosidosis, Generalized Gm1, Type 1 (disorder): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Gangliosidosis, Generalized Gm1, Type 1 (disorder)

Most recent studies have shown that Gangliosidosis, Generalized Gm1, Type 1 (disorder) shares some biological mechanisms with beta-galactosidase-deficiency, fabry-disease, gangliosidoses, gangliosidosis-gm1, gaucher-disease, globoid-cell-leukodystrophy, inborn-errors-of-metabolism, leukodystrophy, leukodystrophy-metachromatic, lipoidosis, lysosomal-storage-diseases, mucopolysaccharidoses, mucopolysaccharidosis-i, mucopolysaccharidosis-iv, mucopolysaccharidosis-type-ivb, niemann-pick-diseases, pfaundler-hurler-syndrome, sphingolipidoses, storage-disease, tay-sachs-disease.

Among the many pathways, these few ones have gauged particular interests from scientists studying Gangliosidosis, Generalized Gm1, Type 1 (disorder), and have been seen in publications frequently: Endocytosis, Excretion, Lipid Storage, Myelination, Pathogenesis, Pigmentation, Translation, Transport

Quite a number of genes have been found to play important roles in Gangliosidosis, Generalized Gm1, Type 1 (disorder), such as AGA, APP, ARSA, ARSH, CTLA4, DEGS1, GALC, GLB1, GUSB, MBL2, MBP, MTCH1, MTSS1, NOD2, PDXP, PLP1, PRDX5, PRG2, PSAP, TDGF1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.